Liquidia Tech Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LIQUIDIA TECH
LIQUIDIA TECH has one approved drug.
There are six US patents protecting LIQUIDIA TECH drugs.
Summary for Liquidia Tech
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Liquidia Tech: | See patent lawsuits for Liquidia Tech |
| PTAB Cases with Liquidia Tech as petitioner: | See PTAB cases with Liquidia Tech as petitioner |
Drugs and US Patents for Liquidia Tech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liquidia Tech | YUTREPIA | treprostinil sodium | POWDER;INHALATION | 213005-002 | May 23, 2025 | RX | Yes | Yes | 11,660,304 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Liquidia Tech | YUTREPIA | treprostinil sodium | POWDER;INHALATION | 213005-002 | May 23, 2025 | RX | Yes | Yes | 11,712,442 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Liquidia Tech | YUTREPIA | treprostinil sodium | POWDER;INHALATION | 213005-003 | May 23, 2025 | RX | Yes | Yes | 11,744,836 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Liquidia Tech | YUTREPIA | treprostinil sodium | POWDER;INHALATION | 213005-002 | May 23, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Liquidia Tech | YUTREPIA | treprostinil sodium | POWDER;INHALATION | 213005-001 | May 23, 2025 | RX | Yes | Yes | 10,898,494 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Liquidia Tech | YUTREPIA | treprostinil sodium | POWDER;INHALATION | 213005-001 | May 23, 2025 | RX | Yes | Yes | 12,390,475 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Liquidia Tech Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 310250 | ⤷ Start Trial |
| Japan | 2019519489 | ⤷ Start Trial |
| Australia | 2023201307 | ⤷ Start Trial |
| Canada | 3023257 | ⤷ Start Trial |
| Canada | 3023257 | ⤷ Start Trial |
| Australia | 2025204321 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
